Endogenous Metabolite (EM) Information
| Endogenous Metabolite (EM) Information | ||||||
|---|---|---|---|---|---|---|
| EM ID |
EM00180
|
|||||
| EM Name |
LysoPC(20:1)
|
|||||
| Synonyms |
LysoPC(20:1(11Z)); 1-(11Z-eicosenoyl)-glycero-3-phosphocholine; LysoPC(20:1w9/0:0); LysoPC(20:1n9/0:0); LyPC(20:1n9/0:0); LyPC(20:1w9/0:0); LPC(20:1); LPC(20:1w9/0:0); LPC(20:1n9/0:0); Lysophosphatidylcholine(20:1w9/0:0); Lysophosphatidylcholine(20:1n9/0:0); PC(20:1(11Z)/0:0); LysoPC(20:1); Lysophosphatidylcholine(20:1); LysoPC(20:1/0:0); LyPC(20:1); Lysophosphatidylcholine(20:1/0:0); LyPC(20:1/0:0); LMGP01050131; 1-eicosenoyl-glycero-3-phosphocholine; LPC(20:1/0:0); 1-(11Z)-icosenoyl-sn-glycero-3-phosphocholine
|
|||||
| Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=52924051"></iframe>
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C28H56NO7P
|
|||||
| Canonical SMILES |
CCCCCCCCC=CCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)O
|
|||||
| InChI |
InChI=1S/C28H56NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-28(31)34-25-27(30)26-36-37(32,33)35-24-23-29(2,3)4/h12-13,27,30H,5-11,14-26H2,1-4H3/b13-12-/t27-/m1/s1
|
|||||
| InChIKey |
YYSFWGQAKJTHRE-MEOKJUQFSA-N
|
|||||
| Pharmaceutical Properties | Molecular Weight | 549.7 | Topological Polar Surface Area | 105 | ||
| Heavy Atom Count | 37 | Rotatable Bond Count | 27 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 7 | |||
| PubChem CID | ||||||
| ChEBI ID |
CHEBI:88685
|
|||||
| DT(s) "handling" This EM | CACT | Transporter Info | Carnitine/acylcarnitine translocase | [1] | ||
| References | ||||||
| 1 | Serum metabolomics reveals that arsenic exposure disrupted lipid and amino acid metabolism in rats: a step forward in understanding chronic arsenic toxicity. Metallomics. 2015 Mar;7(3):544-52. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.